NCT01674712
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
See it on ClinicalTrials.gov ↗556 people
35.6%
64.4%
198 womenmiddle line = equal numbers358 men
- Phase
- PHASE3
- Paid for by
- Abbott
- Finished
- 2013-10
- Health conditions
- Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 60.0 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women,”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women,”
Study titles and rules are shown in their original English.